Dr. Antonio González Martín is a medical oncologist at Clínica Universidad de Navarra in Madrid, Spain. His clinical and research interests focus on gynecological cancers, particularly ovarian cancer, and the development of personalized cancer treatment approaches.

The official hospital profile identifies him as Director of the Cancer Center Clínica Universidad de Navarra and Director of the Department of Medical Oncology. He is also a principal investigator in the Translational Oncology Group.

Gynecological Oncology

Gynecological oncology focuses on cancers affecting the female reproductive system, including ovarian, cervical, uterine, and other gynecological malignancies.

Diagnosis and treatment require consideration of the tumor's location, stage, histological type, molecular characteristics, and the patient's general health. Care may involve medical oncology, gynecological surgery, radiology, pathology, radiation oncology, and genetic counseling.

Dr. González Martín's particular clinical focus is gynecological oncology, making this an important area for patients seeking specialist evaluation of gynecological malignancies.

Ovarian Cancer Treatment

Ovarian cancer can present with different histological and molecular characteristics. Treatment planning generally involves pathology review, imaging, staging, and assessment of whether surgery and systemic treatment are appropriate.

Depending on the diagnosis, treatment may include surgery, platinum-based chemotherapy, targeted medicines, maintenance treatment, or other therapies based on clinical indications.

For selected patients, molecular and genetic testing can help identify relevant treatment options. Decisions regarding treatment should be based on the individual diagnosis and multidisciplinary assessment.

Clinical Research and Personalized Oncology

Dr. González Martín's official biography documents participation as principal investigator in more than 50 clinical trials and as co-investigator in more than 40 trials, many involving breast and gynecological cancers.

His research has included ovarian cancer clinical trials and translational oncology projects. He has also participated in international research collaborations through gynecological oncology organizations.

Translational oncology connects laboratory research with clinical care. In gynecological cancer, this can include research into tumor biology, molecular markers, treatment resistance, and targeted medicines.

Clinical trial access depends on the type and stage of cancer, previous treatment, eligibility criteria, and whether an appropriate study is open.

Academic and Leadership Experience

Dr. González Martín graduated in Medicine from the University of Navarra in 1993 and completed medical oncology specialization at Hospital Universitario Ramón y Cajal in Madrid in 1997.

He worked as an attending medical oncologist at Ramón y Cajal from 1998 to 2008, then led the Medical Oncology Department at MD Anderson Cancer Center from 2009 to 2017.

He joined Clínica Universidad de Navarra as co-director of Medical Oncology in September 2017 and became department director in 2022.

International Patient Information

Patients seeking a gynecological oncology consultation should bring pathology reports, surgical records, imaging studies, molecular or genetic test results, and previous chemotherapy or other treatment details.

These documents support review of the diagnosis and help determine whether further investigations, treatment planning, or clinical trial screening may be appropriate.

Treatment decisions should be made following a comprehensive specialist evaluation.